FASN expression has been reported to be regulated by the human epidermal growth factor receptor HER2 oncogene (erbB2) through phosphatidylinositol 3-kinase (PI3-K)/Akt in breast cancers [63] as well as by mTOR signaling pathways in colorectal cancer cells [64]. This evidence concerns the gene ERBB2 and breast carcinoma.